News und Analysen
![Novus Therapeutics Announces Acquisition of Anelixis Therapeutics](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Novus Therapeutics Announces Acquisition of Anelixis Therapeutics
Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS) today announced it has completed the acquisition of Anelixis Therapeutics, Inc. (“Anelixis”), a privately held clinical stage biotechnology company
![Fuel Tech to Present at the 22nd Annual H.C. Wainwright Global Investment Conference](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
Fuel Tech to Present at the 22nd Annual H.C. Wainwright Global Investment Conference
Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control and water treatment in utility and
![Genprex Appoints William E. Gannon, Jr., MD, MBA, as Vice President of Regulatory Affairs](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
Genprex Appoints William E. Gannon, Jr., MD, MBA, as Vice President of Regulatory Affairs
Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today
![Mannatech Declares Increased Second Quarter 2020 Dividend](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
Mannatech Declares Increased Second Quarter 2020 Dividend
Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced that its Board of Directors declared a cash dividend
![Ammendments to ProtoKinetix AAGP® Protocol for Continuation of Phase 1 Human Trials Have Been Approved by Health Canada](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
Ammendments to ProtoKinetix AAGP® Protocol for Continuation of Phase 1 Human Trials Have Been Approved by Health Canada
ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB: PKTX), a clinical-stage biomedical company, today announced that Dr. James Shapiro has received approval
![Broadway Financial Corporation and CFBanc Corporation to Combine to Create the Largest Black-Led Minority Depository Institution in the U.S.](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
Broadway Financial Corporation and CFBanc Corporation to Combine to Create the Largest Black-Led Minority Depository Institution in the U.S.
CFBanc Corporation (“City First”) in Washington, DC and Broadway Financial Corporation (“Broadway,” Nasdaq: BYFC) in Los Angeles, CA announced today that they have entered into a transformational
![Genprex to Present at The LD 500 Virtual Conference](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Genprex to Present at The LD 500 Virtual Conference
Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today
![Mannatech Concludes Virtual Worldwide Convention](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
Mannatech Concludes Virtual Worldwide Convention
Mannatech, Incorporated (NASDAQ: MTEX) recently concluded their largest virtual live event in the company's 27-year history. In lieu of helping keep attendees safe from the growing COVID-19
![Mannatech Announces Share Repurchase Program](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Mannatech Announces Share Repurchase Program
Mannatech, Incorporated (NASDAQ: MTEX), today announced that its Board of Directors has approved a share repurchase program to acquire up to $1.0 million of its outstanding common stock. The
![1347 Property Insurance Holdings, Inc. Reports Second Quarter 2020 Financial Results](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
1347 Property Insurance Holdings, Inc. Reports Second Quarter 2020 Financial Results
1347 Property Insurance Holdings, Inc. (Nasdaq: PIH) (the “Company”), a holding company which is implementing business plans to operate as a diversified holding company of reinsurance and
![ProtoKinetix AAGP® Moves to Whole Organ Transplantation Testing](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
ProtoKinetix AAGP® Moves to Whole Organ Transplantation Testing
ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB: PKTX), a clinical-stage biomedical company, today announced that due to the results that AAGP® has
![Fuel Tech Reports 2020 Second Quarter Financial Results](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
Fuel Tech Reports 2020 Second Quarter Financial Results
Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control and water treatment in utility and
![Mannatech Reports Second Quarter 2020 Financial Results](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
Mannatech Reports Second Quarter 2020 Financial Results
Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its second quarter of
![Fuel Tech Schedules Second Quarter 2020 Financial Results and Conference Call](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
Fuel Tech Schedules Second Quarter 2020 Financial Results and Conference Call
Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control and water treatment in utility and
![Nonvoice Partners With Bango to Accelerate 5G App Adoption](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
Nonvoice Partners With Bango to Accelerate 5G App Adoption
Bango (AIM: BGO), the mobile commerce company, announces that it has entered a Bango Marketplace partnership agreement with Nonvoice, the leading 5G app agency. Through the partnership, Nonvoice
![Dover Motorsports, Inc. Announces Appointment of Radcliffe Hastings and Michael Tatoian to Its Board of Directors](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Dover Motorsports, Inc. Announces Appointment of Radcliffe Hastings and Michael Tatoian to Its Board of Directors
Dover Motorsports, Inc. (NYSE: DVD) announced that the Board of Directors of the Company, at its regularly scheduled quarterly meeting, appointed Radcliffe Hastings and Michael Tatoian, as
![Genprex to Present at Proactive’s One2One Virtual Investor Forum on August 4, 2020](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Genprex to Present at Proactive’s One2One Virtual Investor Forum on August 4, 2020
Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, announced
![Genprex CEO Participates in a Second-Round Live Interview on the “Big Biz Show”](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
Genprex CEO Participates in a Second-Round Live Interview on the “Big Biz Show”
Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today
![Dover Motorsports, Inc. Reports Results for the Second Quarter of 2020 and Closing of Nashville Land Sale](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Dover Motorsports, Inc. Reports Results for the Second Quarter of 2020 and Closing of Nashville Land Sale
Dover Motorsports, Inc. (NYSE: DVD) today reported results for the three months ended June 30, 2020.
The COVID-19 pandemic caused the postponement of the Company’s scheduled May NASCAR weekend
![Dover Motorsports, Inc. Announces Second Quarter 2020 Earnings Release Date](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Dover Motorsports, Inc. Announces Second Quarter 2020 Earnings Release Date
Dover Motorsports, Inc. (NYSE: DVD) will report its earnings for the second quarter ended June 30, 2020 on the morning of Thursday, July 30, 2020. Commentary from the Company’s executive officers
![Dover International Speedway’s Aug. 21-23 NASCAR Weekend to Be Held Without Fans Due to COVID-19 Concerns](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
Dover International Speedway’s Aug. 21-23 NASCAR Weekend to Be Held Without Fans Due to COVID-19 Concerns
The Aug. 21-23 NASCAR weekend at Dover International Speedway will take place without fans due to concerns surrounding the coronavirus (COVID-19) pandemic.
While the six races at The Monster Mile
![National Institutes of Health (NIH) Awards Research Grant of $2.59 Million to University of Pittsburgh for Diabetes Gene Therapy Technology Licensed by Genprex](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
National Institutes of Health (NIH) Awards Research Grant of $2.59 Million to University of Pittsburgh for Diabetes Gene Therapy Technology Licensed by Genprex
Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today
![Heat Biologics: Erste NBC-Empfehlung mit +1.375% in 5 Monaten](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
Heat Biologics: Erste NBC-Empfehlung mit +1.375% in 5 Monaten
Mit Heat Biologics (WKN: A2JB4Y) kannte die erste Empfehlung des weltweit einzigartig erfolgreichen No Brainer Clubs zuletzt kein Halten mehr. Seit Ende Februar steht eine Kursperformance von
![Amendments to ProtoKinetix AAGP® Protocol for Continuation of Phase 1 Human Trials by the University of Alberta Submitted to Health Canada](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
Amendments to ProtoKinetix AAGP® Protocol for Continuation of Phase 1 Human Trials by the University of Alberta Submitted to Health Canada
ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB: PKTX), a clinical-stage biomedical company, today announced an update to the Press Release of March 24,
![ProtoKinetix AAGP® Dry Eye Program Advancing](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
ProtoKinetix AAGP® Dry Eye Program Advancing
ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB:PKTX), a clinical-stage biomedical company, provides the following update regarding upcoming news in its